Your Location：
Home >
Browse articles >
Cornel iridoid glycoside reduces infarct size measured by magnetic resonance imaging and improves neurological function after focal cerebral ischemia in rats
OriginalPaper | Updated：2021-09-24
|

    • Cornel iridoid glycoside reduces infarct size measured by magnetic resonance imaging and improves neurological function after focal cerebral ischemia in rats

    • Cornel iridoid glycoside reduces infarct size measured by magnetic resonance imaging and improves neurological function after focal cerebral ischemia in rats

    • 中国结合医学杂志（英文版）   页码：1-7

    • DOI：10.1007/s11655-015-2288-x    

      中图分类号：

    Scan for full text

  • Cui-cui Yang (, ), Lin Li (, 等. Cornel iridoid glycoside reduces infarct size measured by magnetic resonance imaging and improves neurological function after focal cerebral ischemia in rats[J/OL]. 1-7. DOI： 10.1007/s11655-015-2288-x.

    Cui-cui Yang  (, ), Lin Li  (, et al. Cornel iridoid glycoside reduces infarct size measured by magnetic resonance imaging and improves neurological function after focal cerebral ischemia in rats[J/OL]. 1-7. DOI： 10.1007/s11655-015-2288-x.

  •  
  •  
FULL TEXT LINK
More>

0

浏览量

0

Downloads

0

CSCD

文章被引用时，请邮件提醒。
Submit
工具集
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Schisandrin B Protects against Ischemic Brain Damage by Regulating PI3K/AKT Signaling in Rats

相关作者

暂无数据

相关机构

Department of Neurology, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian Province, China;Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China
0